Cardiac resynchronization therapy: Past, present, and future

Heart Failure Clinics

Volumn 11, Issue 2, 2015, Pages 287-303

  Chatterjee, Neal A ^a   Singh, Jagmeet P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Biventricular pacing; Cardiac resynchronization therapy; Electrical dyssynchrony; Heart failure

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART FAILURE; HUMAN; META ANALYSIS (TOPIC); MORPHOLOGY; PATIENT CARE; PATIENT SELECTION; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ELECTROCARDIOGRAPHY; FORECASTING; HEART LEFT VENTRICLE FUNCTION; PATHOPHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; TRENDS; VECTORCARDIOGRAPHY;

CARDIAC RESYNCHRONIZATION THERAPY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FORECASTING; HEART FAILURE; HUMANS; PATIENT SELECTION; SEVERITY OF ILLNESS INDEX; VECTORCARDIOGRAPHY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84925965541     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2014.12.007     Document Type: Review

References (123)

1. Brignole M., Auricchio A., Baron-Esquivias G., et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 2013, 15:1070-1118.
2. Epstein A.E., DiMarco J.P., Ellenbogen K.A., et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. JAm Coll Cardiol 2013, 61:e6-e75.
3. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. NEngl J Med 2002, 346:1845-1853.
4. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. NEngl J Med 2004, 350:2140-2150.
5. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. NEngl J Med 2005, 352:1539-1549.
6. Moss A.J., Hall W.J., Cannom D.S., et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. NEngl J Med 2009, 361:1329-1338.
7. Tang A.S., Wells G.A., Talajic M., et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. NEngl J Med 2010, 363:2385-2395.
8. Cazeau S., Ritter P., Bakdach S., et al. Four chamber pacing in dilated cardiomyopathy. Pacing Clin Electrophysiol 1994, 17:1974-1979.
9. Mullens W., Grimm R.A., Verga T., et al. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. JAm Coll Cardiol 2009, 53:765-773.
10. Nelson G.S., Berger R.D., Fetics B.J., et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 2000, 102:3053-3059.
11. Baldasseroni S., Opasich C., Gorini M., et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J 2002, 143:398-405.
12. Hawkins N.M., Wang D., McMurray J.J., et al. Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme. Eur J Heart Fail 2007, 9:510-517.
13. Ghio S., Constantin C., Klersy C., et al. Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration. Eur Heart J 2004, 25:571-578.
14. Liu L., Tockman B., Girouard S., et al. Left ventricular resynchronization therapy in a canine model of left bundle branch block. Am J Physiol Heart Circ Physiol 2002, 282:H2238-H2244.
15. Han W., Chartier D., Li D., et al. Ionic remodeling of cardiac Purkinje cells by congestive heart failure. Circulation 2001, 104:2095-2100.
16. Kirk J.A., Kass D.A. Electromechanical dyssynchrony and resynchronization of the failing heart. Circ Res 2013, 113:765-776.
17. Agnetti G., Kaludercic N., Kane L.A., et al. Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts. Circ Cardiovasc Genet 2010, 3:78-87.
18. Wang S.B., Foster D.B., Rucker J., et al. Redox regulation of mitochondrial ATP synthase: implications for cardiac resynchronization therapy. Circ Res 2011, 109:750-757.
19. Aiba T., Hesketh G.G., Barth A.S., et al. Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy. Circulation 2009, 119:1220-1230.
20. Chakir K., Daya S.K., Aiba T., et al. Mechanisms of enhanced beta-adrenergic reserve from cardiac resynchronization therapy. Circulation 2009, 119:1231-1240.
21. Prinzen F.W., Hunter W.C., Wyman B.T., et al. Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. JAm Coll Cardiol 1999, 33:1735-1742.
22. Rosen B.D., Fernandes V.R., Nasir K., et al. Age, increased left ventricular mass, and lower regional myocardial perfusion are related to greater extent of myocardial dyssynchrony in asymptomatic individuals: the multi-ethnic study of atherosclerosis. Circulation 2009, 120:859-866.
23. Vernooy K., Verbeek X.A., Peschar M., et al. Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion. Eur Heart J 2005, 26:91-98.
24. Prinzen F.W., Vernooy K., De Boeck B.W., et al. Mechano-energetics of the asynchronous and resynchronized heart. Heart Fail Rev 2011, 16:215-224.
25. Ukkonen H., Beanlands R.S., Burwash I.G., et al. Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism. Circulation 2003, 107:28-31.
26. Cazeau S., Leclercq C., Lavergne T., et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. NEngl J Med 2001, 344:873-880.
27. Cleland J.G., Freemantle N., Daubert J.C., et al. Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report from the CARE-HF study. Heart 2008, 94:278-283.
28. Kadish A., Dyer A., Daubert J.P., et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. NEngl J Med 2004, 350:2151-2158.
29. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. NEngl J Med 2002, 346:877-883.
30. Myerburg R.J., Reddy V., Castellanos A. Indications for implantable cardioverter-defibrillators based on evidence and judgment. JAm Coll Cardiol 2009, 54:747-763.
31. Higgins S.L., Hummel J.D., Niazi I.K., et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. JAm Coll Cardiol 2003, 42:1454-1459.
32. Abraham W.T., Young J.B., Leon A.R., et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 2004, 110:2864-2868.
33. Linde C., Abraham W.T., Gold M.R., et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. JAm Coll Cardiol 2008, 52:1834-1843.
34. Yu C.M., Chan Y.S., Zhang Q., et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. JAm Coll Cardiol 2006, 48:2251-2257.
35. Achilli A., Sassara M., Ficili S., et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS. JAm Coll Cardiol 2003, 42:2117-2124.
36. Beshai J.F., Grimm R.A., Nagueh S.F., et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. NEngl J Med 2007, 357:2461-2471.
37. Ruschitzka F., Abraham W.T., Singh J.P., et al. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. NEngl J Med 2013, 369:1395-1405.
38. Thibault B., Harel F., Ducharme A., et al. Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial. Circulation 2013, 127:873-881.
39. Delgado V., Ypenburg C., van Bommel R.J., et al. Assessment of left ventricular dyssynchrony by speckle tracking strain imaging comparison between longitudinal, circumferential, and radial strain in cardiac resynchronization therapy. JAm Coll Cardiol 2008, 51:1944-1952.
40. Saba S., Marek J., Schwartzman D., et al. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial. Circ Heart Fail 2013, 6:427-434.
41. Chung E.S., Leon A.R., Tavazzi L., et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 2008, 117:2608-2616.
42. Bilchick K.C., Dimaano V., Wu K.C., et al. Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy. JACC Cardiovasc Imaging 2008, 1:561-568.
43. Sohal M., Duckett S.G., Zhuang X., et al. Aprospective evaluation of cardiovascular magnetic resonance measures of dyssynchrony in the prediction of response to cardiac resynchronization therapy. JCardiovasc Magn Reson 2014, 16:58.
44. Truong Q.A., Hoffmann U., Singh J.P. Potential uses of computed tomography for management of heart failure patients with dyssynchrony. Crit Pathw Cardiol 2008, 7:185-190.
45. Leclercq C., Cazeau S., Lellouche D., et al. Upgrading from single chamber right ventricular to biventricular pacing in permanently paced patients with worsening heart failure: the RD-CHF Study. Pacing Clin Electrophysiol 2007, 30(Suppl 1):S23-S30.
46. Sweeney M.O., Hellkamp A.S., Ellenbogen K.A., et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003, 107:2932-2937.
47. Wilkoff B.L., Cook J.R., Epstein A.E., et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002, 288:3115-3123.
48. Curtis A.B., Worley S.J., Adamson P.B., et al. Biventricular pacing for atrioventricular block and systolic dysfunction. NEngl J Med 2013, 368:1585-1593.
49. Funck R.C., Blanc J.J., Mueller H.H., et al. Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the 'Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)' study. Europace 2006, 8:629-635.
50. Kandala J., Altman R.K., Park M.Y., et al. Clinical, laboratory, and pacing predictors of CRT response. JCardiovasc Transl Res 2012, 5:196-212.
51. Leyva F., Nisam S., Auricchio A. 20 years of cardiac resynchronization therapy. JAm Coll Cardiol 2014, 64:1047-1058.
52. Fornwalt B.K., Sprague W.W., BeDell P., et al. Agreement is poor among current criteria used to define response to cardiac resynchronization therapy. Circulation 2010, 121:1985-1991.
53. Yu C.M., Bleeker G.B., Fung J.W., et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 2005, 112:1580-1586.
54. Hsu J.C., Solomon S.D., Bourgoun M., et al. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) study. JAm Coll Cardiol 2012, 59:2366-2373.
55. Rickard J., Kumbhani D.J., Popovic Z., et al. Characterization of super-response to cardiac resynchronization therapy. Heart Rhythm 2010, 7:885-889.
56. Voigt J., Sasha John M., Taylor A., et al. Areevaluation of the costs of heart failure and its implications for allocation of health resources in the United States. Clin Cardiol 2014, 37:312-321.
57. Auricchio A., Fantoni C., Regoli F., et al. Characterization of left ventricular activation in patients with heart failure and left bundle-branch block. Circulation 2004, 109:1133-1139.
58. Fantoni C., Kawabata M., Massaro R., et al. Right and left ventricular activation sequence in patients with heart failure and right bundle branch block: a detailed analysis using three-dimensional non-fluoroscopic electroanatomic mapping system. JCardiovasc Electrophysiol 2005, 16:112-119. [discussion: 120-1].
59. Rodriguez L.M., Timmermans C., Nabar A., et al. Variable patterns of septal activation in patients with left bundle branch block and heart failure. JCardiovasc Electrophysiol 2003, 14:135-141.
60. Richman J.L., Wolff L. Left bundle branch block masquerading as right bundle branch block. Am Heart J 1954, 47:383-393.
61. Sipahi I., Carrigan T.P., Rowland D.Y., et al. Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Arch Intern Med 2011, 171:1454-1462.
62. Gold M.R., Thebault C., Linde C., et al. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study. Circulation 2012, 126:822-829.
63. Cleland J.G., Abraham W.T., Linde C., et al. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J 2013, 34:3547-3556.
64. Sipahi I., Chou J.C., Hyden M., et al. Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Am Heart J 2012, 163:260-267.e3.
65. Upadhyay G.A., Choudhry N.K., Auricchio A., et al. Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. JAm Coll Cardiol 2008, 52:1239-1246.
66. Wilton S.B., Leung A.A., Ghali W.A., et al. Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm 2011, 8:1088-1094.
67. Healey J.S., Hohnloser S.H., Exner D.V., et al. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT). Circ Heart Fail 2012, 5:566-570.
68. Gasparini M., Leclercq C., Lunati M., et al. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry). JACC Heart Fail 2013, 1:500-507.
69. Yin J., Hu H., Wang Y., et al. Effects of atrioventricular nodal ablation on permanent atrial fibrillation patients with cardiac resynchronization therapy: a systematic review and meta-analysis. Clin Cardiol 2014, 37(11):707-715.
70. Fung J.W., Szeto C.C., Chan J.Y., et al. Prognostic value of renal function in patients with cardiac resynchronization therapy. Int J Cardiol 2007, 122:10-16.
71. Garg N., Thomas G., Jackson G., et al. Cardiac resynchronization therapy in CKD: a systematic review. Clin J Am Soc Nephrol 2013, 8:1293-1303.
72. Chatterjee N.A., Upadhyay G.A., Singal G., et al. Pre-capillarypulmonary hypertension and right ventricular dilation predict clinical outcome in cardiac resynchronization therapy. JACC Heart Fail 2014, 2:230-237.
73. Adelstein E.C., Saba S. Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy. Am Heart J 2007, 153:105-112.
74. Bilchick K.C., Kuruvilla S., Hamirani Y.S., et al. Impact of mechanical activation, scar, and electrical timing on cardiac resynchronization therapy response and clinical outcomes. JAm Coll Cardiol 2014, 63:1657-1666.
75. Arshad A., Moss A.J., Foster E., et al. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. JAm Coll Cardiol 2011, 57:813-820.
76. Zusterzeel R., Curtis J.P., Canos D.A., et al. Sex-specificmortality risk by QRS morphology and duration in patients receiving CRT: results from the NCDR. JAm Coll Cardiol 2014, 64:887-894.
77. Blendea D., Shah R.V., Auricchio A., et al. Variability of coronary venous anatomy in patients undergoing cardiac resynchronization therapy: a high-speed rotational venography study. Heart Rhythm 2007, 4:1155-1162.
78. Derval N., Steendijk P., Gula L.J., et al. Optimizing hemodynamics in heart failure patients by systematic screening of left ventricular pacing sites: the lateral left ventricular wall and the coronary sinus are rarely the best sites. JAm Coll Cardiol 2010, 55:566-575.
79. Singh J.P., Klein H.U., Huang D.T., et al. Left ventricular lead position and clinical outcome in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) trial. Circulation 2011, 123:1159-1166.
80. Gold M.R., Yu Y., Singh J.P., et al. The effect of left ventricular electrical delay on AV optimization for cardiac resynchronization therapy. Heart Rhythm 2013, 10:988-993.
81. Singh J.P., Fan D., Heist E.K., et al. Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy. Heart Rhythm 2006, 3:1285-1292.
82. Duckett S.G., Ginks M., Shetty A.K., et al. Invasive acute hemodynamic response to guide left ventricular lead implantation predicts chronic remodeling in patients undergoing cardiac resynchronization therapy. JAm Coll Cardiol 2011, 58:1128-1136.
83. Faris O.P., Evans F.J., Dick A.J., et al. Endocardial versus epicardial electrical synchrony during LV free-wall pacing. Am J Physiol Heart Circ Physiol 2003, 285:H1864-H1870.
84. Ellenbogen K.A., Gold M.R., Meyer T.E., et al. Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy. Circulation 2010, 122:2660-2668.
85. Ryu K., D'Avila A., Heist E.K., et al. Simultaneous electrical and mechanical mapping using 3D cardiac mapping system: novel approach for optimal cardiac resynchronization therapy. JCardiovasc Electrophysiol 2010, 21:219-222.
86. Rinaldi C.A., Burri H., Thibault B., et al. Areview of multisite pacing to achieve cardiac resynchronization therapy. Europace 2015, 17(1):7-17.
87. Yoshida K., Seo Y., Yamasaki H., et al. Effect of triangle ventricular pacing on haemodynamics and dyssynchrony in patients with advanced heart failure: a comparison study with conventional bi-ventricular pacing therapy. Eur Heart J 2007, 28:2610-2619.
88. Pappone C., Calovic Z., Vicedomini G., et al. Multipoint left ventricular pacing improves acute hemodynamic response assessed with pressure-volume loops in cardiac resynchronization therapy patients. Heart Rhythm 2014, 11:394-401.
89. Leclercq C., Gadler F., Kranig W., et al. Arandomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure. JAm Coll Cardiol 2008, 51:1455-1462.
90. Pappone C., Calovic Z., Vicedomini G., et al. Multipoint left ventricular pacing in a single coronary sinus branch improves mid-term echocardiographic and clinical response to cardiac resynchronization therapy. JCardiovasc Electrophysiol 2015, 26:58-63.
91. MultiPoint Pacing IDE Study (MPP IDE). Available at: Accessed October 6, 2014. http://clinicaltrials.gov/show/NCT01786993.
92. More Response on Cardiac Resynchronization Therapy with MultiPoint Pacing (MORE-CRT MPP). Available at: Accessed October 6, 2014. http://clinicaltrials.gov/show/NCT02006069.
93. Kamath G.S., Balaram S., Choi A., et al. Long-term outcome of leads and patients following robotic epicardial left ventricular lead placement for cardiac resynchronization therapy. Pacing Clin Electrophysiol 2011, 34:235-240.
94. Auricchio A., Delnoy P.P., Butter C., et al. Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the Wireless Stimulation Endocardially for CRT (WiSE-CRT) study. Europace 2014, 16:681-688.
95. Alternate Site Cardiac Resynchronization (ALSYNC) study. Available at: Accessed October 6, 2014. http://clinicaltrials.gov/show/NCT01277783.
96. Auricchio A., Stellbrink C., Block M., et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation 1999, 99:2993-3001.
97. Gras D., Gupta M.S., Boulogne E., et al. Optimization of AV and VV delays in the real-world CRT patient population: an international survey on current clinical practice. Pacing Clin Electrophysiol 2009, 32(Suppl 1):S236-S239.
98. Barold S.S., Ilercil A., Herweg B. Echocardiographic optimization of the atrioventricular and interventricular intervals during cardiac resynchronization. Europace 2008, 10(Suppl 3):iii88-iii95.
99. Kamdar R., Frain E., Warburton F., et al. Aprospective comparison of echocardiography and device algorithms for atrioventricular and interventricular interval optimization in cardiac resynchronization therapy. Europace 2010, 12:84-91.
100. Singh J.P., Abraham W.T., Chung E.S., et al. Clinical response with adaptive CRT algorithm compared with CRT with echocardiography-optimized atrioventricular delay: a retrospective analysis of multicentre trials. Europace 2013, 15:1622-1628.
101. Boriani G., Biffi M., Muller C.P., et al. Aprospective randomized evaluation of VV delay optimization in CRT-D recipients: echocardiographic observations from the RHYTHM II ICD study. Pacing Clin Electrophysiol 2009, 32(Suppl 1):S120-S125.
102. Leon A.R., Abraham W.T., Brozena S., et al. Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure. JAm Coll Cardiol 2005, 46:2298-2304.
103. Marsan N.A., Bleeker G.B., Van Bommel R.J., et al. Cardiac resynchronization therapy in patients with ischemic versus non-ischemic heart failure: differential effect of optimizing interventricular pacing interval. Am Heart J 2009, 158:769-776.
104. Delnoy P.P., Ritter P., Naegele H., et al. Association between frequent cardiac resynchronization therapy optimization and long-term clinical response: a post hoc analysis of the Clinical Evaluation on Advanced Resynchronization (CLEAR) pilot study. Europace 2013, 15:1174-1181.
105. Ritter P., Delnoy P.P., Padeletti L., et al. Arandomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs standard methods. Europace 2012, 14:1324-1333.
106. Martin D.O., Lemke B., Birnie D., et al. Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. Heart Rhythm 2012, 9:1807-1814.
107. Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D (RESPOND CRT). Available at: Accessed October 6, 2014. http://clinicaltrials.gov/show/NCT01534234.
108. Birnie D., Lemke B., Aonuma K., et al. Clinical outcomes with synchronized left ventricular pacing: analysis of the adaptive CRT trial. Heart Rhythm 2013, 10:1368-1374.
109. Thibault B., Ducharme A., Harel F., et al. Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex>/=120 milliseconds. Circulation 2011, 124:2874-2881.
110. Singh J.P., Rosenthal L.S., Hranitzky P.M., et al. Device diagnostics and long-term clinical outcome in patients receiving cardiac resynchronization therapy. Europace 2009, 11:1647-1653.
111. Auricchio A., Gold M.R., Brugada J., et al. Long-term effectiveness of the combined minute ventilation and patient activity sensors as predictor of heart failure events in patients treated with cardiac resynchronization therapy: results of the clinical evaluation of the physiological diagnosis function in the PARADYM CRT device trial (CLEPSYDRA) study. Eur J Heart Fail 2014, 16:663-670.
112. Vegh E.M., Kandala J., Orencole M., et al. Device-measured physical activity versus six-minute walk test as a predictor of reverse remodeling and outcome after cardiac resynchronization therapy for heart failure. Am J Cardiol 2014, 113:1523-1528.
113. Hayes D.L., Boehmer J.P., Day J.D., et al. Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 2011, 8:1469-1475.
114. Lakkireddy D., Di Biase L., Ryschon K., et al. Radiofrequency ablation of premature ventricular ectopy improves the efficacy of cardiac resynchronization therapy in nonresponders. JAm Coll Cardiol 2012, 60:1531-1539.
115. Altman R.K., Parks K.A., Schlett C.L., et al. Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes. Eur Heart J 2012, 33:2181-2188.
116. CRT Implant Strategy Using the Longest Electrical Delay for Non-left Bundle Branch Block Patients (ENHANCE CRT). Available at: Accessed October 6, 2014. http://clinicaltrials.gov/show/NCT01983293.
117. Kandala J., Upadhyay G.A., Altman R.K., et al. QRS morphology, left ventricular lead location, and clinical outcome in patients receiving cardiac resynchronization therapy. Eur Heart J 2013, 34:2252-2262.
118. Multicenter Automatic Defibrillator Implantation Trial - Chemotherapy-Induced Cardiomyopathy (MADIT-CHIC). Available at: Accessed October 6, 2014. http://clinicaltrials.gov/show/NCT02164721.
119. Manfredi J.A., Al-Khatib S.M., Shaw L.K., et al. Association between left ventricular ejection fraction post-cardiac resynchronization treatment and subsequent implantable cardioverter defibrillator therapy for sustained ventricular tachyarrhythmias. Circ Arrhythm Electrophysiol 2013, 6:257-264.
120. Russo A.M., Stainback R.F., Bailey S.R., et al. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. JAm Coll Cardiol 2013, 61:1318-1368.
121. Kini V., Soufi M.K., Deo R., et al. Appropriateness of primary prevention implantable cardioverter-defibrillators at the time of generator replacement: are indications still met?. JAm Coll Cardiol 2014, 63:2388-2394.
122. Kantharia B.K. Deterioration from improved heart failure status in a recipient of a cardiac resynchronization therapy-defibrillator (CRT-D) following a single inappropriate shock. Int J Cardiol 2012, 161:e55-e57.
123. Maggioni A.P., Anker S.D., Dahlstrom U., et al. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 2013, 15:1173-1184.